Palisade Capital Management

ElMindA is an Israeli company based in Herzliya, with an additional office in Glenview, Illinois, founded in 2006. It specializes in developing a tool for diagnosing, monitoring, and treating brain-related disorders using its proprietary Brain Network Activation (BNA) technology. This technology integrates electroencephalography, event-related potential testing, machine learning, advanced algorithms, and large-population databases to visualize and evaluate the complex neuro-physiological interconnections of the human brain in action. By capturing detailed electrophysiological patterns related to specific functions evoked by repeatable tasks, BNA creates high-resolution, three-dimensional representations of functional neural pathways. These representations help assess brain function and health, aiding in the management of conditions such as mild traumatic brain injury, major depressive disorder, Parkinson’s disease, multiple sclerosis, ADHD, and mild cognitive impairment.

Brickell Biotech, Inc. is a clinical-stage pharmaceutical company based in Boulder, Colorado, established in 2009. The company specializes in identifying, developing, and commercializing prescription therapeutics aimed at treating debilitating skin diseases in the United States. Its lead product candidate, sofpironium bromide, is currently undergoing phase 3 clinical trials for the treatment of primary axillary hyperhidrosis. In addition to this, Brickell Biotech has a pipeline that includes potential novel therapeutics for hyperhidrosis and other common dermatological conditions. The company also has a collaboration agreement with AnGes, Inc. to develop a novel DNA vaccine candidate for COVID-19.

Neurologix, Inc. is a clinical-stage biotechnology company based in Fort Lee, New Jersey, focused on the discovery and development of gene transfer therapies for serious brain and central nervous system disorders. Established in 1999, the company aims to provide therapeutic alternatives to conventional surgical and pharmacological treatments. Its primary research centers on gene therapy for Parkinson's disease and epilepsy, both of which significantly impact patients' quality of life. Additionally, Neurologix is involved in the development of gene transfers for various neurodegenerative and metabolic disorders, including Huntington's disease, depression, and genetically-based obesity. The company's innovative approach seeks to address unmet medical needs by leveraging cutting-edge gene therapy technologies.

Send Word Now is the worldwide provider of enterprise communications services. Their easy-to-use, web-based and mobile solutions are deployed by businesses, government agencies, universities and non-profit organizations to ensure fast, effective communication when it is needed the most. Send Word Now was founded in 2001, by a group of individuals who recognized the need for immediate, reliable and multimodal crisis communications after the tragedies of September 11, 2001. Since that time, organizations across the globe have faced a multitude of natural and man-made disruptions, creating a heightened focus on business continuity, regulatory compliance, security and the ability to audit information flow. Further, today’s borderless business environment and increasingly mobile workforce have surfaced new needs for operations-focused communication and collaboration. Send Word Now is successfully transforming the way organizations communicate globally, both for emergency situations, and for every day, time-sensitive interactions. Their enterprise-class emergency notification system is capable of transmitting tens of thousands of voice and text messages in minutes, while providing a full audit trail for after action reporting and follow-up. Their mobile conferencing, collaboration and workflow solutions keep employees informed and connected to the people and information they need. And, everything is backed by their 100% Uptime reliability guarantee, and unmatched 24x7x365 customer support. In emergencies, or every day. When rapid, effective communication is essential for success, rely on Send Word Now for innovative, secure and reliable notification and collaboration solutions.

Mitralign is a privately held medical device company based in a suburb of Boston, Massachusetts. It specializes in developing catheter-based technologies for the percutaneous treatment of functional mitral regurgitation, a global and life-threatening cardiac condition. The company's innovative Mitralign system mimics surgical annuloplasty by delivering a series of implants directly into the mitral annulus via a catheter, reducing its size and improving valve function. Mitralign is backed by top-tier venture capitalists and has strategic investments from major cardiovascular device companies.

Shoe Sensation, Inc. is a regional chain of family footwear retail stores based in Jeffersonville, Indiana, with locations across multiple states including Arkansas, Illinois, Indiana, Iowa, Kentucky, Michigan, Minnesota, Missouri, Ohio, Pennsylvania, Tennessee, and West Virginia. Founded in 1974, the company specializes in providing a wide variety of quality name-brand footwear for men, women, and children, catering to the needs of customers of all ages. The product range includes athletic shoes, running shoes, walking shoes, safety toe boots, heels, and sneakers, ensuring a diverse selection that meets the footwear requirements of families. Shoe Sensation aims to deliver a better-branded merchandise mix, emphasizing quality and customer satisfaction.

Ikonisys, Inc. is a medical diagnostic company focused on the design, manufacture, and marketing of advanced diagnostic products for cancer detection and genetic disorder screening. Headquartered in New Haven, Connecticut, Ikonisys offers a range of innovative tools, including the Ikoniscope Robotic Microscope, which automates slide handling and image analysis, reducing human error in testing. Their product line features various oncoFISH applications, such as those for bladder cancer and HER2 status in breast tissue, as well as tools for detecting genetic abnormalities in prostate tissue biopsies. The company is committed to transforming diagnostic medicine by enabling early and accurate disease detection through a combination of cutting-edge technology and scientific research, ultimately assisting healthcare professionals in providing optimal patient care. Founded in 1999, Ikonisys continues to advance its capabilities in non-invasive diagnostic solutions.

Language Weaver, Inc. specializes in developing and licensing automated translation solutions tailored for multinationals, government organizations, and translation providers. The company’s offerings include the LW Enterprise Translation Server, which facilitates on-site language translation within enterprises, and the LW Custom Enterprise Translation Server, designed for specialized domains such as information technology, automotive, medical, and finance. Additionally, Language Weaver provides LW Translation On Demand, an on-demand translation service, alongside LW Custom Translation On Demand, which is hosted on a dedicated server. The company also offers LW Professional Services, encompassing software training, the development of custom language pairs, and the preparation of parallel data to enhance translation accuracy and efficiency.

Achieve3000, Inc. is a cloud-based literacy platform that provides differentiated literacy solutions aimed at enhancing reading comprehension, fluency, vocabulary, and writing proficiency for students in grades 2 through 12. Founded in 2000 and based in Red Bank, New Jersey, the company offers a range of educational programs, including KidBiz3000 for younger students, TeenBiz3000 for middle and high school learners, and Spark3000 for adult education. Achieve3000's proprietary software customizes content delivery based on individual reading levels, ensuring that each student engages with material suited to their abilities. The platform serves various educational institutions, including schools and school districts, and is designed to align with state curricula while supporting remote and on-site instruction.

Versura is a business-to-business exchange focused on enhancing opportunities within the higher education finance sector. It provides an Internet-based service that simplifies the preferred lender selection process for educational institutions, allowing schools to tailor loan programs to maximize value for both their institutions and students. Additionally, Versura offers an open digital marketplace for lenders and financial institutions, facilitating connections with colleges and universities nationwide. This platform enables lenders to broaden their market reach while also allowing loan sellers to connect with potential buyers interested in acquiring all or part of their loan portfolios.